CAROL YACULA: Open Payments
NPI 1336691815 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 9 payments from 8 companies in 2025. Trend: 2023 $1,263 · 2024 $377 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| ABBVIE INC. | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Exelixis Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: Fabhalta, ELAHERE, Onivyde, CABOMETYX, ALYMSYS, KEYTRUDA, Amtagvi, LIBTAYO.
Industry payments across DE — which companies pay providers there.
